title: Optimizing Dvl PDZ domain inhibitor by exploring chemical space.
abstract: Because of advances in the high-throughput screening technology, identification of a hit that can bind to a target protein has become a relatively easy task; however, in the process of drug discovery, the following hit-to-lead and lead optimization still remain challenging. In a typical hit-to-lead and lead optimization process, the analogues of the most promising hits are synthesized for the development of structure-activity relationship (SAR) analysis, and in turn, in the effort of optimization of lead compounds, such analysis provides guidance for the further synthesis. The synthesis processes are usually long and labor-intensive. In silico searching has becoming an alternative approach to explore SAR especially with millions of compounds ready to be screened and most of them can be easily obtained. Here, we report our discovery of 15 new Dishevelled PDZ domain inhibitors by using such an approach. In our studies, we first developed a pharmacophore model based on NSC668036, an inhibitor previously identified in our laboratory; based on the model, we then screened the ChemDiv database by using an algorithm that combines similarity search and docking procedures; finally, we selected potent inhibitors based on docking analysis and examined them by using NMR spectroscopy. NMR experiments showed that all the 15 compounds we chose bound to the PDZ domain tighter than NSC668036.
authors.affiliation: Department of Structural Biology, St. Jude Children's Research Hospital, 322 N. Lauderdale St., MS #311, Memphis, TN 38105, USA.
authors.forename: Jufang
authors.initials: J
authors.lastname: Shan
authors.forename: Jie J
authors.initials: JJ
authors.lastname: Zheng
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000037:antagonists & inhibitors*; D000072261:Dishevelled Proteins; D008958:Models, Molecular; D019906:Nuclear Magnetic Resonance, Biomolecular; D054731:PDZ Domains; D010750:Phosphoproteins / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D000072261:Dishevelled Proteins; D010750:Phosphoproteins
references.citation: J Chem Inf Model. 2005 Jan-Feb;45(1):160-9
references.pmid: 15667141
references.citation: J Am Chem Soc. 2003 Oct 8;125(40):12074-5
references.pmid: 14518976
references.citation: Biochem Biophys Res Commun. 2004 Sep 10;322(1):326-32
references.pmid: 15313210
references.citation: J Biomol NMR. 1995 Nov;6(3):277-93
references.pmid: 8520220
references.citation: Cancer Res. 2007 Jan 15;67(2):573-9
references.pmid: 17234765
references.citation: Dev Cell. 2002 Apr;2(4):449-61
references.pmid: 11970895
references.citation: Nat Rev Drug Discov. 2006 Dec;5(12):997-1014
references.pmid: 17139285
references.citation: Nat Rev Drug Discov. 2003 May;2(5):369-78
references.pmid: 12750740
references.citation: Drug Discov Today. 2006 Aug;11(15-16):741-8
references.pmid: 16846802
references.citation: J Med Chem. 2004 Mar 25;47(7):1739-49
references.pmid: 15027865
references.citation: Biochemistry. 2003 Jun 17;42(23):7068-76
references.pmid: 12795602
references.citation: J Chem Inf Model. 2005 Jan-Feb;45(1):177-82
references.pmid: 15667143
references.citation: Curr Opin Chem Biol. 1997 Jun;1(1):72-8
references.pmid: 9667842
references.citation: Angew Chem Int Ed Engl. 2006 Jun 2;45(23):3790-5
references.pmid: 16671149
references.citation: Chem Biol. 2006 Dec;13(12):1247-51
references.pmid: 17185220
references.citation: Proteins. 1999 Nov 1;37(2):228-41
references.pmid: 10584068
references.citation: Protein Eng. 1995 Feb;8(2):127-34
references.pmid: 7630882
references.citation: Nat Rev Drug Discov. 2004 Dec;3(12):1047-56
references.pmid: 15573103
references.citation: Curr Opin Chem Biol. 2004 Jun;8(3):255-63
references.pmid: 15183323
references.citation: Am J Pharmacogenomics. 2004;4(4):263-76
references.pmid: 15287820
references.citation: Biochemistry. 2005 Nov 29;44(47):15495-503
references.pmid: 16300398
references.citation: J Mol Med (Berl). 2005 Dec;83(12):955-63
references.pmid: 16283145
references.citation: Mol Cell. 2003 Nov;12(5):1251-60
references.pmid: 14636582